The next few years will continue to be busy for hemp industries, and we expect there to be dramatic changes across the board, both good and bad. Here are our top four predictions for 2020.

Move over CBD and THC, new cannabinoids are on the way.

A study published by Nature.com has revealed the discovery of two previously unknown cannabinoids, now named THCP and CBDP. In tests on mice, researchers found that THCP demonstrated “an affinity for CB1 receptor more than thirty-fold higher compared to the one reported for THC,” making it much stronger than THC.

For all the challenges that marijuana stocks have faced in the past year, including a lack of profitability and analysts being bearish on the industry, there's been no shortage of investors who have been willing to buy shares of cannabis companies despite the risks involved. The biggest risk for any cannabis investor today centers around how sensitive the stocks are and how volatile they can be in response to new developments in the industry, or just analyst opinions. This volatility shouldn't be ignored, as investors could see their portfolios lose significant value in a short amount of time.

The World Health Organization estimates that 1 in 13 people on earth suffer from anxiety. 

Anxiety can manifest itself in various forms, with social anxiety being one of the most common forms.

Lightning-fast. High-speed. Breakneck. 

This is how quick the modern cannabis experience is changing — and nobody knows this better than the consumers who are witnessing this rapid growth firsthand. From dispensary shelves filled with products you’ve never seen before to the increasingly serious push for legal cannabis nationwide, to cannabis consumption lounges opening up in a few lucky locations, we are living through the cannabis renaissance. And yet, more expansive change is still on the horizon.  

Since CBD can help management anxiety, improve cognitive function and sleep, and reduce chronic pain, it can help improve one’ s overall health.  

Every December 31st, you cobble together a list of things you intend to do in the new year in your ongoing quest to improve yourself. But by mid-February, it’s back to the couch and Netflix.

If you set health and wellness goals as part of your New Year’s resolutions, here’s some suggestions for how CBD can help you actually keep these promises. 

There is an extensive, ever-growing body of peer-reviewed medical research which attest to the efficacy of cannabis in aiding restful sleep for patients of all ages.

Chronic insomnia and other sleep disorders are extremely common in the United States, affecting an estimated 50 to 70 million adults.  While some are able to find relief in conventional medications, such as Lunesta and Ambien, pharmaceutical sleeping aids are not effective for every patient. Moreover, prescription sleep medication can have bothersome side effects, have dangerous interactions with other medications, lead to physical dependence, and even pose a risk of overdose.

This was supposed to be the year that marijuana stocks went from being perceived as a speculative investment to something that long-term investors would be proud to add their portfolios. And it certainly looked as if that would be the case after the first quarter. Through the end of March, the Horizons Marijuana Life Sciences ETF, the first cannabis-focused exchange-traded fund, had gained more than 50% for the year.

Then everything fell apart.

What's the single biggest impediment for Canadian marijuana stocks? It isn't the retail environment in Canada, which should improve in the near future. No, the biggest issue is that Canadian companies can't expand into the U.S. pot market and retain their listings on the major stock exchanges in Canada and the U.S.

It's a huge problem because the U.S. is home to the largest marijuana market in the world. As long as marijuana remains illegal at the federal level, Canadian companies won't be able to capitalize on the U.S. opportunity except by moving into the hemp market.

The cannabis industry's growth potential is one of the key reasons investors have been buying up pot stocks in recent years. One of the most recent estimates, by research company Fortune Business Insights, projects the global cannabis market will be worth more than $97 billion by 2026. Estimates like this sound impressive and are very effective in attracting investors. But investors shouldn't be quick to rely on these numbers for a couple of important reasons.